Background illustration for clinical trials search

Endocrine Clinical Trials

Browse 341 endocrine clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Study of Endocrine-Related Conditions and Physiology

for
Endocrine Disease
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 18 - 70+

Code: NCT03867448

Recruiting

Rare and Atypical Diabetes Network

for
Diabetes Mellitus, Diabetes Mellitus Progression,
Location: Boston MA, Brooklyn NY, New York NY, Baltimore MD,
Sponsor: University of South Florida

Sex: All

Age: 0+

Code: NCT05544266

Recruiting

Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients

for
Multiple Endocrine Neoplasia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT03048266

Recruiting

AnovaOS Network Powered Patient Registry

for
Infectious Disease, Neoplasms,
Location: Arlington Heights IL
Sponsor: Anova Enterprises, Inc

Sex: All

Age: 18+

Code: NCT05013944

Recruiting

Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)

for
Multiple Endocrine Neoplasia, Pancreatic Neuroendocrine Tumors,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT03053999

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

for
Hormone Receptor Positive, HER2-low or HER2-ultralow,
Location: New York NY
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07701941

Phase1, Phase2, Recruiting
New

Sex Hormones and Aging

for
Menopause, Menopausal Hormone Therapy, Aging
Location: Ann Arbor MI
Sponsor: University of Michigan

Sex: Female

Age: 50 - 70

Code: NCT07848438

Recruiting
New

Diabetes, Insulin, Gut, Enteric Supplementation Trial

for
Gestational Diabetes Mellitus (GDM), Blood Glucose,
Location: Fredericton
Sponsor: University of New Brunswick

Sex: Female

Age: 19+

Code: NCT07682077

Recruiting
New

Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial

for
Recurrent Prostate Adenocarcinoma,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: Male

Age: 18+

Code: NCT07650240

Phase2, Recruiting
New

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease

for
Recurrent Small Cell Lung Cancer,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT07509034

Phase1, Recruiting
New

A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer

for
Hormone Receptor Positive Early Breast Cancer
Location: Margate FL, Port Orange FL, Beverly Hills CA
Sponsor: Rovi Pharmaceuticals Laboratories

Sex: Female

Age: 18 - 70+

Code: NCT07401381

Phase1, Recruiting

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Boston MA, Horsham PA, Philadelphia PA, Richmond VA,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06369285

Phase2, Recruiting

A Study of VET3-TGI in Patients With Solid Tumors

for
Solid Tumor, Adult, Microsatellite Stable Colorectal Cancer,
Location: Miami FL, Pittsburgh PA, Indianapolis IN, Houston TX,
Sponsor: KaliVir Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06444815

Phase1, Recruiting

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

for
Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer,
Location: St Louis MO, Westwood KS
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06374459

Phase1, Phase2, Recruiting

Long-term Follow-up of Subjects Treated With CAR T Cells

for
Long Term Adverse Effects, CAR-T, Duty to Follow Up, Adult,
Location: Boston MA
Sponsor: Marcela V. Maus, M.D.,Ph.D.

Sex: All

Age: 18+

Code: NCT05024175

Recruiting

Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer

for
Hormone Receptor-Positive Breast Cancer,
Location: Long Branch NJ, Elizabeth NJ, Newark NJ, Livingston NJ,
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18+

Code: NCT06518837

Phase2, Recruiting

Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics

for
Obesity, Gestational Diabetes, Lifestyle, Healthy,
Location: New Orleans LA
Sponsor: Tulane University

Sex: Female

Age: 18+

Code: NCT06116149

Recruiting

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

for
Neuroendocrine Tumors Unresectable,
Location: Baltimore MD, Fairfax VA, Chapel Hill NC, Miami FL,
Sponsor: Perspective Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05636618

Phase1, Phase2, Recruiting

The Impact of Overnight Nutrition Support on Sleep and Circadian Rhythm Disruption in the ICU

for
Feeding Patterns, Sleep, Glucose Intolerance
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT04737200

Recruiting

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

for
Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor,
Location: Boston MA, Baltimore MD, Bethesda MD, Toronto,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 12+

Code: NCT04924075

Phase2, Recruiting